• 1
    Briscoe, D. M., Ganz, P., Alexander, S. I., Melder, R. J., Jain, R. K., Cotran, R. S. and Lichtman, A. H., The problem of chronic rejection: influence of leukocyte-endothelial interactions. Kidney Int. Suppl. 1997. 58: S2227.
  • 2
    Pober, J. S. and Cotran, R. S., Immunologic interactions of T lymphocytes with vascular endothelium. Adv. Immunol. 1991. 50: 261302.
  • 3
    Briscoe, D. M., Henault, L. E., Geehan, C., Alexander, S. I. and Lichtman, A. H., Human endothelial cell costimulation of T cell IFN-gamma production. J. Immunol. 1997. 159: 32473256.
  • 4
    Greenwald, R. J., Latchman, Y. E. and Sharpe, A. H., Negative co-receptors on lymphocytes. Curr. Opin. Immunol. 2002. 14: 391396.
  • 5
    Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999. 11: 141151.
  • 6
    Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R. et al., PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001. 2: 261268.
  • 7
    Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova,T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C. et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp.Med. 2000. 192: 10271034.
  • 8
    Mazanet, M. M. and Hughes, C. C., B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 2002. 169: 35813588.
  • 9
    Eppihimer, M. J., Gunn, J., Freeman, G. J., Greenfield, E. A., Chernova, T., Erickson, J. and Leonard, J. P., Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 2002. 9: 133145.
  • 10
    Biedermann, B. C. and Pober, J. S., Human endothelial cells induce and regulate cytolytic T cell differentiation. J. Immunol. 1998. 161: 46794687.
  • 11
    Dengler, T. J. and Pober, J. S., Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J. Immunol. 2000. 164: 51465155.
  • 12
    Kreisel, D., Krupnick, A. S., Balsara, K. R., Riha, M., Gelman, A. E., Popma, S. H., Szeto, W. Y., Turka, L. A. and Rosengard, B. R., Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J. Immunol. 2002. 169: 61546161.
  • 13
    Pober, J. S., Immunobiology of human vascular endothelium. Immunol. Res. 1999. 19: 225232.
  • 14
    Marelli-Berg, F. M., Scott, D., Bartok, I., Peek, E., Dyson,J. and Lechler, R. I., Activated murine endothelial cells have reduced immunogenicity for CD8+ T cells: a mechanism of immunoregulation? J. Immunol. 2000. 165: 41824189.
  • 15
    Lim, Y. C., Garcia-Cardena, G., Allport, J. R., Zervoglos, M., Connolly, A. J., Gimbrone, M. A., Jr. and Luscinskas, F. W., Heterogeneity of endothelial cells from different organ sites in T cell subset recruitment. Am. J. Pathol. 2003. 162: 15911601.
  • 16
    Ma, W. and Pober, J. S., Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J. Immunol. 1998. 161: 21582167.
  • 17
    Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A. and Freeman, G. J., Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003. 170: 12571266.
  • 18
    Pober, J. S., Kluger, M. S. and Schechner, J. S., Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann. NY Acad. Sci. 2001. 941: 1225.
  • 19
    Yellin, M. J., Brett, J., Baum, D., Matsushima, A., Szabolcs, M., Stern, D. and Chess, L., Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediatedsignals. J. Exp. Med. 1995. 182: 18571864.
  • 20
    Savage, C. O., Brooks, C. J., Harcourt, G. C., Picard, J. K., King, W., Sansom, D. M. and Willcox, N., Human vascular endothelial cells process and present autoantigen to human T cell lines. Int. Immunol. 1995. 7: 471479.
  • 21
    Hughes, C. C., Savage, C. O. and Pober, J. S., Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J. Exp. Med. 1990. 171: 14531467.
  • 22
    Savage, C. O., Hughes, C. C., Pepinsky, R. B., Wallner, B. P., Freedman, A. S. and Pober, J. S., Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells. Cell Immunol. 1991. 137: 150163.
  • 23
    Perez, V. L., Henault, L. and Lichtman, A. H., Endothelial antigen presentation: stimulation ofpreviously activated but not naive TCR-transgenic mouse T cells. Cell Immunol. 1998. 189: 3140.
  • 24
    Liang, L. and Sha, W. C., The right place at the right time: novel B7 family members regulate effector T cell responses. Curr. Opin. Immunol. 2002. 14: 384390.
  • 25
    Carreno, B. M. and Collins, M., The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 2002. 20: 2953.
  • 26
    Sharpe, A. H. and Freeman, G. J., The B7-CD28 superfamily. Nat. Rev. Immunol. 2002. 2: 116126.
  • 27
    Pober, J. S., Orosz, C. G., Rose, M. L. and Savage, C. O., Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996. 61: 343349.
  • 28
    Kreisel, D., Krupnick, A. S., Gelman, A. E., Engels, F. H., Popma, S. H., Krasinskas, A. M., Balsara, K. R., Szeto, W. Y., Turka, L. A. and Rosengard, B. R., Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat. Med. 2002. 8: 233239.
  • 29
    Eriksson, U., Kurrer, M. O., Sebald, W., Brombacher, F. and Kopf, M., Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J. Immunol. 2001. 167: 54645469.
  • 30
    Nagano, H., Mitchell, R. N., Taylor, M. K., Hasegawa, S., Tilney, N. L. and Libby, P., Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J. Clin. Invest. 1997. 100: 550557.
  • 31
    Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N. and Honjo, T., Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001. 291:319322.
  • 32
    Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J. and Sharpe, A. H., Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune resposnes. Eur. J. Immunol. 2003. 33: 26962705.
  • 33
    Dong, H., Strome, S. E., Matteson, E. L., Moder, K. G., Flies, D. B., Zhu, G., Tamura, H., Driscoll, C. L. and Chen, L., Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 2003. 111: 363370.
  • 34
    Radhakrishnan, S., Nguyen, L. T., Ciric, B., Ure, D. R., Zhou, B., Tamada, K., Dong, H., Tseng, S. Y., Shin, T., Pardoll, D. M., Chen, L., Kyle, R. A., Rodriguez, M. and Pease, L. R., Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells. J. Immunol. 2003. 170: 18301838.
  • 35
    Bennett, F., Luxenberg, D., Ling, V., Wang, I. M., Marquette, K., Lowe, D., Khan, N., Veldman, G., Jacobs, K. A., Valge-Archer, V. E., Collins, M. and Carreno, B. M., Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 2003. 170: 711718.
  • 36
    Selenko-Gebauer, N., Majdic, O., Szekeres, A., Hofler, G., Guthann, E., Korthauer, U., Zlabinger, G., Steinberger, P., Pickl, W. F., Stockinger, H., Knapp, W. and Stockl, J., B7-H1 (programmed death-1 ligand) on dendritic cells is involvedin the induction and maintenance of T cell anergy. J. Immunol. 2003. 170: 36373644.
  • 37
    Grabie, N., Delfs, M., Westrich, J., Love, V., Stavrakis, G., Ahmad, F., Seidman, C., Seidman, J. and Lichtman, A. H., IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J. Clin. Invest. 2003. 111: 671680.
  • 38
    Ozkaynak, E., Wang, L., Goodearl, A., McDonald, K., Qin, S., O'Keefe, T., Duong, T., Smith, T., Gutierrez-Ramos, J. C., Rottman, J. B., Coyle, A. J. and Hancock, W. W., Programmed death-1 targeting can promote allograft survival. J. Immunol. 2002. 169: 65466553.
  • 39
    Carbone, F. R., T cell receptor antagonist peptides induce positive selection. Cell 1994. 76: 1727.
  • 40
    Carbone, F. R. and Bevan, M. J., Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 1989. 169: 603612.
  • 41
    Luscinskas, F., Brock, A., Arnaout, M. and Gimbrone, M., Jr, Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J. Immunol. 1989. 142: 22572263.
  • 42
    Warner, S. J., Auger, K. R. and Libby, P., Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J. Exp. Med. 1987. 165: 13161331.